TY - JOUR
T1 - OTX2 mutations contribute to the otocephaly-dysgnathia complex
AU - Chassaing, Nicolas
AU - Sorrentino, Susanna
AU - Davis, Erica E.
AU - Martin-Coignard, Dominique
AU - Iacovelli, Anthony
AU - Paznekas, William
AU - Webb, Bryn D.
AU - Faye-Petersen, Ona
AU - Encha-Razavi, Férechté
AU - Lequeux, Leopoldine
AU - Vigouroux, Adeline
AU - Yesilyurt, Ahmet
AU - Boyadjiev, Simeon A.
AU - Kayserili, Hülya
AU - Loget, Philippe
AU - Carles, Dominique
AU - Sergi, Consolato
AU - Puvabanditsin, Surasak
AU - Chen, Chih Ping
AU - Etchevers, Heather C.
AU - Katsanis, Nicholas
AU - Mercer, Catherine L.
AU - Calvas, Patrick
AU - Jabs, Ethylin Wang
PY - 2012/6
Y1 - 2012/6
N2 - Background Otocephaly or dysgnathia complex is characterised by mandibular hypoplasia/agenesis, ear anomalies, microstomia, and microglossia; the molecular basis of this developmental defect is largely unknown in humans. Methods and results This study reports a large family in which two cousins with micro/anophthalmia each gave birth to at least one child with otocephaly, suggesting a genetic relationship between anophthalmia and otocephaly. OTX2, a known microphthalmia locus, was screened in this family and a frameshifting mutation was found. The study subsequently identified in one unrelated otocephalic patient a sporadic OTX2 mutation. Because OTX2 mutations may not be sufficient to cause otocephaly, the study assayed the potential of otx2 to modify craniofacial phenotypes in the context of known otocephaly gene suppression in vivo. It was found that otx2 can interact genetically with pgap1, prrx1, and msx1 to exacerbate mandibular and midline defects during zebrafish development. However, sequencing of these loci in the OTX2-positive families did not unearth likely pathogenic lesions, suggesting further genetic heterogeneity and complexity. Conclusion Identification of OTX2 involvement in otocephaly/dysgnathia in humans, even if loss of function mutations at this locus does not sufficiently explain the complex anatomical defects of these patients, suggests the requirement for a second genetic hit. Consistent with this notion, trans suppression of otx2 and other developmentally related genes recapitulate aspects of the otocephaly phenotype in zebrafish. This study highlights the combined utility of genetics and functional approaches to dissect both the regulatory pathways that govern craniofacial development and the genetics of this disease group.
AB - Background Otocephaly or dysgnathia complex is characterised by mandibular hypoplasia/agenesis, ear anomalies, microstomia, and microglossia; the molecular basis of this developmental defect is largely unknown in humans. Methods and results This study reports a large family in which two cousins with micro/anophthalmia each gave birth to at least one child with otocephaly, suggesting a genetic relationship between anophthalmia and otocephaly. OTX2, a known microphthalmia locus, was screened in this family and a frameshifting mutation was found. The study subsequently identified in one unrelated otocephalic patient a sporadic OTX2 mutation. Because OTX2 mutations may not be sufficient to cause otocephaly, the study assayed the potential of otx2 to modify craniofacial phenotypes in the context of known otocephaly gene suppression in vivo. It was found that otx2 can interact genetically with pgap1, prrx1, and msx1 to exacerbate mandibular and midline defects during zebrafish development. However, sequencing of these loci in the OTX2-positive families did not unearth likely pathogenic lesions, suggesting further genetic heterogeneity and complexity. Conclusion Identification of OTX2 involvement in otocephaly/dysgnathia in humans, even if loss of function mutations at this locus does not sufficiently explain the complex anatomical defects of these patients, suggests the requirement for a second genetic hit. Consistent with this notion, trans suppression of otx2 and other developmentally related genes recapitulate aspects of the otocephaly phenotype in zebrafish. This study highlights the combined utility of genetics and functional approaches to dissect both the regulatory pathways that govern craniofacial development and the genetics of this disease group.
UR - http://www.scopus.com/inward/record.url?scp=84864080446&partnerID=8YFLogxK
U2 - 10.1136/jmedgenet-2012-100892
DO - 10.1136/jmedgenet-2012-100892
M3 - Article
C2 - 22577225
AN - SCOPUS:84864080446
SN - 0022-2593
VL - 49
SP - 373
EP - 379
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 6
ER -